Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CNP | EXPD |
|---|---|---|
| Price | $36.85 | $186.75 |
| Change today | ▲ 0.12% | ▲ 1.14% |
| Market cap | $24.27B | $24.28B |
| Return, 3 months | -15.2% | +12.0% |
| Return, year to date | -2.3% | +26.0% |
| Return, 1 year | -1.3% | +55.3% |
| P/E (TTM) | 21.9 | 27.2 |
| P/B | 2.1 | 11.5 |
| P/E percentile vs own 5y | 54th | 95th |
| Dividend yield | 2.44% | 0.85% |
| Revenue growth (YoY, latest qtr) | +10.7% | +32.1% |
| Net profit growth (YoY) | +23.2% | +45.3% |
| Gross margin | 46.7% | 12.9% |
| Operating margin | 23.2% | 9.8% |
| Net margin | 11.6% | 7.6% |
| Return on equity | 9.8% | 42.6% |
| Analyst target vs. price | +24.6% | -2.5% |
| Analyst buy share | 60% | 30% |
| RSI (14) | 30 | 45 |
| 30-day volatility | 17.4% | 18.6% |
| Max drawdown, 1 year | -18.2% | -15.9% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
